2021-11-12T08:51:22-06:00 2020-12-31 390919055 RITZ HOLMAN LLP 330 E KILBOURN AVE SUITE 550 MILWAUKEE WI 53202 990 2020-01-01 911766321 THE AMERICAN SOCIETY OF GENE & CELL THERAPY AMER 4142781341 20800 SWENSON DR NO 300 WAUKESHA WI 53186 PALOMA H GIANGRANDE PHD TREASURER 4142781341 2021-11-12 1 PALOMA GIANGRANDE PHD 999009999 KATY L SOMMER P00273273 4142711451 2021-11-11 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z X PALOMA H GIANGRANDE PHD 20800 SWENSON DR NO 300 WAUKESHA WI 53186 6516210 0 X WWW.ASGCT.ORG X 1996 WA ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE. 14 14 18 14 28400 23933 1124475 21126 5227852 6362242 100334 84023 56604 48819 6509265 6516210 388630 387500 0 0 8495 920840 0 0 156040 4294717 3203091 4691842 4511431 1817423 2004779 9695835 11546982 1394198 1230556 8301637 10316426 X ASGCT'S MISSION IS TO ADVANCE KNOWLEDGE, AWARENESS, AND EDUCATION LEADING TO THE DISCOVERY AND CLINICAL APPLICATION OF GENETIC AND CELLULAR THERAPIES TO ALLEVIATE HUMAN DISEASE. 0 0 1276768 2761406 ANNUAL MEETING: THIS IS THE PRIMARY VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE ANNUAL MEETING REPRESENTS THE MAJOR EDUCATIONAL INITIATIVE OF THE SOCIETY. 589153 2136186 MOLECULAR THERAPY JOURNALS: PUBLISHING SCHOLARLY JOURNALS IS THE SECOND MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE JOURNALS ARE THE WAY ASGCT EDUCATES AND UPDATES RESEARCHERS, CLINICIANS, AND STUDENTS ON THE LATEST ADVANCES IN THE DEVELOPMENT OF NOVEL THERAPEUTICS. 474608 387500 1000 ADVOCACY: ADVOCACY IS THE THIRD MAJOR VEHICLE FOR CARRYING OUT THE EDUCATIONAL MISSION OF ASGCT. THE DEFINING VALUE OF ADVOCACY IS "GENE AND CELL THERAPY WILL HAVE A FINANCIAL IMPACT ON PATIENTS, PROVIDERS, AND PAYERS. ASGCT IS COMMITTED TO UNDERSTANDING THAT IMPACT AND EDUCATING DECISION-MAKERS ENGAGED IN DEVELOPING POLICIES THAT INFLUENCE PATIENT ACCESS TO TREATMENTS." 1024598 1463650 OTHER PROGRAMS INCLUDE: GENE EDITING WORKSHOP, CELL THERAPY WORKSHOP, COMMERCIALIZATION WORKSHOP, CLINICAL TRIALS TRAINING COURSE, POLICY SUMMIT, CAREER DEVELOPMENT PROGRAM, COVID SYMPOSIUM, CAREER DEVELOPMENT PROGRAM PATIENT EDUCATION PROGRAM, AND THE NEWSLETTER. 1024598 1463650 3365127 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 0 1 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 18 1 1 1 0 0 0 0 0 0 0 0 0 X 14 14 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 X 501 FINANCIAL MANAGEMENT 8479755304 2549 WAUKEGAN RD 210 BANNOCKBURN IL 60015 STEPHEN J RUSSELL MD PHD PRESIDENT 5.00 X X 0 0 0 MATTHEW WILSON MD PHD DIRECTOR 3.00 X 0 0 0 JENNIFER E ADAIR PHD DIRECTOR 3.00 X 0 0 0 PHILIP GREGORY DPHIL DIRECTOR 3.00 X 0 0 0 MARITZA MCINTYRE PHD DIRECTOR 3.00 X 0 0 0 TERRENCE R FLOTTE MD SECRETARY 5.00 X X 0 0 0 STEPHEN L HART PHD DIRECTOR 3.00 X 0 0 0 PALOMA H GIANGRANDE PHD TREASURER 5.00 X X 0 0 0 RICHARD MORGAN PHD DIRECTOR 3.00 X 0 0 0 HANS-PETER KIEM MD PHD VICE PRESIDENT 5.00 X X 0 0 0 FEDERICO MINGOZZI PHD DIRECTOR 3.00 X 0 0 0 ANASTASIA KHVOROVA PHD DIRECTOR 3.00 X 0 0 0 BEVERLY DAVIDSON PHD PRESIDENT ELECT 5.00 X X 0 0 0 MARCELA V MAUS MD PHD DIRECTOR 3.00 X 0 0 0 DAVID BARRETT EXECUTIVE DIRECTOR 40.00 X 185043 0 10253 185043 0 10253 1 0 1 0 EXECUTIVE DIRECTOR INC 555 E WELLS STSTE 1100 MILWAUKEE WI 53202 MANAGEMENT 922906 BGR GOVERNMENT AFFAIRS LLC 601 THIRTEENTH STREET NW 11TH FL WASHINGTON DC 20005 ADVOCACY 180000 ROBERT M FREDERICKSON CONSULTING INC 710 SUMMIT AVE EAST SEATTLE WA 98102 EDITORIAL SERVICES 179615 3 21126 21126 REGISTRATIONS 900099 2894976 2894976 JOURNAL INCOME 511120 2136186 2136186 MEMBERSHIP DUES AND AS 900099 791050 791050 EXHIBIT REVENUE 900099 492280 492280 COVID SYMPOSIUM 900099 42500 42500 5250 5250 6362242 84023 84023 ADVERTISING 541900 28400 28400 JOB POSTING 541900 15398 15398 MISCELLANEOUS 541900 5021 5021 48819 6516210 6382661 28400 84023 300000 300000 73296 73296 14204 14204 195295 126942 39059 29294 598854 389256 119769 89829 16948 11016 3390 2542 45151 29349 9029 6773 64592 41985 12918 9689 924468 644912 279556 66472 56207 10265 47662 47662 347908 328636 19272 108481 91105 17376 251237 123860 127377 353961 208513 145448 119417 77622 23882 17913 642 642 466809 466348 461 28541 28541 25886 19517 6369 JOURNAL EXPENSES 192254 192254 REGISTRATION EXPENSE 170105 170105 MEMBERSHIP RECRUIT AND 80199 80199 CHARITABLE DONATIONS 10000 10000 9049 9049 4511431 3365127 990264 156040 2983236 4147144 1788185 2061495 60000 578635 1218924 336711 129741 24784 5565 1131 19219 3919137 3900424 28800 46535 0 23500 9695835 11546982 189036 267107 1204790 962023 372 1426 1394198 1230556 X 7886637 10316426 415000 0 8301637 10316426 9695835 11546982 2004779 425010 -415000 0 X X 0 1 X 1 0 X 548880 640649 1483553 1735740 812176 5220998 1999523 2807499 3348315 4616587 5571192 18343116 2548403 3448148 4831868 6352327 6383368 23564114 41000 15000 85000 141000 256889 576918 387600 1221407 297889 591918 387600 85000 1362407 22201707 27635 40688 60563 100334 84023 313243 27635 40688 60563 100334 84023 313243 10653 13200 22350 25200 28400 99803 30 13070 15487 31407 20419 80413 2586721 3515106 4930268 6509268 6516210 24057573 0.92290 0.88750 0.01300 0.01290 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 208002 1710 34487 244199 158984 1875 47143 208002 163601 2326 -6943 158984 129245 6790 27566 163601 107791 8717 12737 129245 1.00000 0 0 24784 5565 19219 19219 1426 1426 X 6941220 425010 425010 6516210 0 6516210 4511431 0 4511431 0 4511431 PART V, LINE 4: THE BOARD DESIGNATED ENDOWMENT FUNDS ARE INTENDED TO BE USED IN THE FUTURE TO OFFER RESEARCH GRANT(S) TO A QUALIFIED MEMBER(S) OF ASGCT. PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS CLASSIFIED AS OTHER THAN A PRIVATE FOUNDATION. HOWEVER, INCOME FROM CERTAIN ACTIVITIES, PRIMARILY ADVERTISING, NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE IS SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. AS OF DECEMBER 31, 2020, THE ORGANIZATION HAD A LIABILITY OF $1,426 FOR UNRELATED BUSINESS INCOME TAX (UBIT). MANAGEMENT HAS REVIEWED ALL TAX POSITIONS RECOGNIZED IN PREVIOUSLY FILED TAX RETURNS AND THOSE EXPECTED TO BE TAKEN IN FUTURE TAX RETURNS. AS OF DECEMBER 31, 2020, THE ORGANIZATION HAD NO AMOUNTS RELATED TO UNRECOGNIZED INCOME TAX BENEFITS AND NO AMOUNTS RELATED TO ACCRUED INTEREST AND PENALTIES. THE ORGANIZATION DOES NOT ANTICIPATE ANY SIGNIFICANT CHANGES TO UNRECOGNIZED INCOME TAX BENEFITS OVER THE NEXT YEAR. THE ORGANIZATION IS CURRENTLY NOT UNDER AUDIT BY ANY FEDERAL OR STATE TAXING AUTHORITY. 1 EUROPE GRANTS AND OTHER ASSISTANCE RESEARCH AWARDS 3445 ASIA & PACIFIC GRANTS AND OTHER ASSISTANCE TRAVEL AWARDS 10759 0 0 0 0 0 0 14204 0 14204 RESEARCH AWARDS EUROPE 2 3445 WIRE FMV TRAVEL AWARDS ASIA & THE PACIFIC 10 10759 WIRE FMV 0 0 0 0 0 0 PART III ACCOUNTING METHOD: 1 JOHNS HOPKINS UNIVERSITY 12529 COLLECTIONS DR CHICAGO IL 60693 520595110 501(C)(3) 50000 FMV CAREER DEVELOPMENT WASHINGTON UNIVERSITY CAMPUS BOX 1034 700 ROSEDALE AVE ST LOUIS MO 63112 430653611 501(C)(3) 50000 FMV CAREER DEVELOPMENT TRUSTEES OF THE UNIVERSITY PA 3451 WALNUT STREET 5TH FL PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 FMV CAREER DEVELOPMENT MASSACHUSETTS GEN HOSPITAL PO BOX 414876 BOSTON MA 02241 042697983 501(C)(3) 50000 FMV CAREER DEVELOPMENT MASSACHUSETTS INSTITUTE OF TECHNOLOGY 600 TECHNOLOGY SQUARE BUILDING NE49-4000 CAMBRIDGE MA 02139 041203594 501(C)(3) 50000 FMV CAREER DEVELOPMENT COLUMBIA UNIVERSITY PO BOX 29789 GENERAL POST OFFICE NEW YORK NY 10087 135598093 501(C)(3) 50000 FMV CAREER DEVELOPMENT 6 RESEARCH AWARDS 68 73296 FMV PART I, LINE 2: EACH YEAR ASGCT GIVES EXCELLENCE IN RESEARCH AWARDS TO ASGCT ASSOCIATE MEMBERS WHO RECEIVED THE HIGHEST ABSTRACT SCORES OF THOSE SUBMITTED TO THE ASGCT ANNUAL MEETING. THE SCORES ARE GIVEN THROUGH A PEER REVIEW PROCESS BY THE ABSTRACT REVIEW COMMITTEES. THE AWARDEES RECEIVE A $500 CASH AWARD AND TRAVEL REIMBURSEMENT AWARD (UP TO $500) TO ATTEND THE ANNUAL MEETING. THE OUTSTANDING NEW INVESTIGATOR AWARDS ARE GIVEN TO UP TO FOUR ASGCT ACTIVE MEMBERS WHO HAVE BEEN NOMINATED BY TWO ASGCT ACTIVE MEMBERS. THE NOMINEES MUST BE SEVEN YEARS OR FEWER FROM THEIR FIRST ASSISTANT PROFESSORSHIP AND BE CONDUCTING INDEPENDENT RESEARCH. THE NOMINATIONS ARE SUBMITTED TO THE ASGCT ADVISORY COUNCIL FOR CONSIDERATION. THE ADVISORY COUNCIL THEN SUBMITS THE RECOMMENDATION TO THE ASGCT BOARD OF DIRECTORS FOR APPROVAL. THE AWARDEES ARE GIVEN A $1,000 CASH AWARD AND PRESENT THEIR WORK DURING THE OUTSTANDING NEW INVESTIGATORS SYMPOSIUM AT THE ASGCT ANNUAL MEETING. THE EDITOR-IN-CHIEF OF THE MOLECULAR THERAPY JOURNAL RECEIVES A $25,000 STIPEND AND EACH DEPUTY EDITOR RECEIVES A $5,000 STIPEND FROM ASGCT IN THE LAST QUARTER OF EACH YEAR OF THE POSITION. THE STIPEND AMOUNT IS REVIEWED BY THE BOARD DURING THE BUDGETING PROCESS AND WRITTEN INTO AGREEMENT WITH EACH NEW TERM OF THE EDITOR-IN-CHIEF. X X X 0 0 0 0 0 0 0 0 0 DAVID BARRETT EXECUTIVE DIRECTOR 185043 0 0 0 0 0 4560 0 5693 0 195296 0 0 0 FORM 990, PART VI, SECTION A, LINE 3 LINE 3 EXPLANATION - ASGCT WAS IN CONTRACT FOR A PORTION OF 2020 WITH EXECUTIVE DIRECTOR, INC., AN ASSOCIATION MANAGEMENT COMPANY. FORM 990, PART VI, SECTION A, LINE 6 LINE 6 EXPLANATION - MEMBERSHIP IN THE SOCIETY IS DEPENDENT ON THE APPLICANT ADEQUATELY DEMONSTRATING COMPLIANCE WITH THE REQUIREMENTS FOR MEMBERSHIP AS DEFINED IN THE BYLAWS AND OTHERWISE BY THE BOARD OF DIRECTORS OF THE SOCIETY. THE MEMBERS OF THE SOCIETY ARE (A) MEMBERS: INDIVIDUALS WHO HAVE MANIFESTED AN INTEREST IN ANY DISCIPLINE IMPORTANT TO GENE THERAPY, CELL THERAPY, OR MANUFACTURING TECHNOLOGIES FOR GENE AND CELL DELIVERY AS EVIDENCED BY WORK IN THE FIELD, (B) ASSOCIATE MEMBERS: INDIVIDUALS WHO ARE CURRENTLY ENROLLED IN AN UNDERGRADUATE PROGRAM, POSTDOCTORAL FELLOWS PROGRAM OR GRADUATE STUDIES PROGRAM OR WHO ARE CURRENTLY EMPLOYED AS A LABORATORY MANAGER, TECHNICIAN, ASSISTANT, OR ANY OTHER CLERICAL LABORATORY POSITION IN GENE AND CELL THERAPY RESEARCH PROGRAMS ARE ELIGIBLE FOR ASSOCIATE MEMBERSHIP IN THE SOCIETY (C) REDUCED DUES MEMBERS: INDIVIDUALS WHO RESIDE IN COUNTRIES DESIGNATED AS "LOW INCOME OR "LOWER-MIDDLE INCOME" BY THE WORLD BANK (BASED ON GROSS NATIONAL INCOME PER CAPITA) AND WHO OTHERWISE FULFILL THE REQUIREMENTS FOR MEMBER OR ASSOCIATE MEMBER STATUS SHALL BE ELIGIBLE FOR REDUCED DUES- MEMBER OR REDUCED DUES-ASSOCIATE MEMBER STATUS. (D) TRANSITIONAL MEMBERS: INDIVIDUALS WHO FULFILL THE REQUIREMENTS OF MEMBER SHALL BE ELIGIBLE FOR TRANSITIONAL MEMBERSHIP FOR NO MORE THAN TWO (2) YEARS, WHICH STATUS PROVIDES FOR THE SAME PRIVILEGES AND MEMBER BENEFITS AS A MEMBER EXCEPT THAT MEMBERSHIP DUES SHALL BE AT A DISCOUNTED RATE AS DETERMINED BY THE BOARD OF DIRECTORS. (E) EMERITUS MEMBERS: ANY MEMBER OF THE SOCIETY WHO HAS BEEN IN GOOD STANDING FOR THE MOST RECENT THREE CONSECUTIVE YEARS, UPON ATTAINING AGE SIXTY-FIVE (65), AND RETIREMENT FROM ACTIVE PRACTICE OR RESEARCH REQUEST THAT HIS OR HER MEMBERSHIP STATUS BE TRANSITIONED TO EMERITUS MEMBERSHIP BY MAKING WRITTEN APPLICATION TO THE CHAIR OF THE MEMBERSHIP COMMITTEE. FORM 990, PART VI, SECTION A, LINE 7A LINE 7A EXPLANATION - ACTIVE MEMBERS IN GOOD STANDING SHALL BE ENTITLED TO VOTE ON ALL MATTERS TO BE VOTED ON BY MEMBERS OF THE SOCIETY, INCLUDING, WITHOUT LIMITATION, ELECTING OFFICERS AND DIRECTORS OF THE SOCIETY. ANY MATTER TO BE DECIDED BY A VOTE OF MEMBERS SHALL, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS OR IN CHAPTER 24.03RCW OF THE WASHINGTON NONPROFIT CORPORATION ACT (OR ANY SUCCESSOR PROVISION), BE DECIDED BY MAJORITY VOTE OF MEMBERS PRESENT IN PERSON OR BY PROXY AT A MEETING OF THE MEMBERS. ASSOCIATE MEMBERS AND EMERITUS MEMBERS OF THE SOCIETY SHALL NOT HAVE VOTING RIGHTS. FORM 990, PART VI, SECTION A, LINE 7B LINE 7B EXPLANATION - SEE DESCRIPTION IN 7A. FORM 990, PART VI, SECTION B, LINE 11B LINE 11B EXPLANATION - THE FORM 990 AND ALL REQUIRED SCHEDULES ARE PROVIDED TO THE FINANCE COMMITTEE AND BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. ONCE APPROVED THE FORM IS SIGNED BY THE APPROPRIATE OFFICER AND FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PRIOR TO EACH MEETING OF THE BOARD OF DIRECTORS, EACH DIRECTOR IS ASKED TO REVIEW THE MEETING AGENDA AND MEETING MATERIALS. AFTER REVIEWING, EACH DIRECTOR IS ASKED TO DISCLOSE ANY CONFLICT OF INTEREST TO THE SOCIETY'S EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR DISCUSSES THE CONFLICT WITH THE EXECUTIVE COMMITTEE TO DETERMINE THE APPROPRIATE REMEDIAL ACTION BASED ON THE DISCLOSED CONFLICT. SPEAKERS PRESENTING AT A SOCIETY MEETING ARE REQUIRED TO FILL OUT A DISCLOSURE DOCUMENT AND A FACULTY COMPLIANCE DOCUMENT PRIOR TO SPEAKING. THE DOCUMENTS ARE REVIEWED BY THE SOCIETY. ANY SPEAKERS WHO HAVE A CONFLICT ARE ALSO REQUIRED TO SUBMIT THEIR PRESENTATION SLIDES FOR REVIEW AND INCLUDE A DISCLOSURE SLIDE PRIOR TO THEIR PRESENTATION SO THAT THE AUDIENCE IS AWARE OF THE RELATIONSHIPS THEY HAVE TO DISCLOSE. THE SOCIETY PRODUCES AND DISTRIBUTES TO EACH PROGRAM ATTENDEE A PRINTED DISCLOSURE DOCUMENT THAT COMPLIES ANY DISCLOSURES OF EVERY FACULTY MEMBER. THE SOCIETY ALSO DISTRIBUTES TWO SURVEYS AT EACH PROGRAM: ONE TO THE CHAIR OF THE SESSION AND ONE TO EACH AUDIENCE MEMBER WHICH ASKS THEM TO INDICATE IF THE PRESENTATIONS BY ANY OF THE FACULTY CONTAINED BIAS. FORM 990, PART VI, SECTION B, LINE 15 IN 2020, WE RELIED ON THE ADVICE OF AN INDEPENDENT CONSULTANT (WESTMAN & ASSOCIATES) TO ASSESS ALL NEWLY CREATED POSITIONS AND DETERMINE MARKET RATE BASED ON SEVERAL DATA, INCLUDING ASSOCIATION FORUM AND ASAE SALARY DATA. WE THEN USED THIS MARKET RATE DATA TO SET INDIVIDUAL SALARIES. FORM 990, PART VI, SECTION C, LINE 19 ASGCT MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FORM 990/990-T AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. ALL SUCH REQUESTS SHOULD BE IN WRITING AND ACCOMPANIED BY A $20 REPRODUCTION AND HANDLING CHARGE IF PRINT COPY IS REQUESTED. MEMBERS OF THE BOARD RECEIVING AN INQUIRY MUST ADVISE STAFF OF THE REQUEST WITHIN A REASONABLE TIME AFTER THE INQUIRY IS RECEIVED. THE BYLAWS CAN ALSO BE FOUND ON THE ASGCT WEBSITE. FORM 990, PART XII, LINE 2C: THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR